These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2171956)

  • 21. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (S)-UH-301 antagonizes (R)-8-OH-DPAT-induced cardiovascular effects in the rat.
    Björk L; Lindgren S; Hacksell U; Lewander T
    Eur J Pharmacol; 1991 Jul; 199(3):367-70. PubMed ID: 1833212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation.
    Koenig JI; Gudelsky GA; Meltzer HY
    Eur J Pharmacol; 1987 May; 137(1):1-8. PubMed ID: 2956114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion.
    Lorens SA; Van de Kar LD
    Neuroendocrinology; 1987 Apr; 45(4):305-10. PubMed ID: 2952898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the hypothermic and hyperglycaemic effects of 8-OH-DPAT by alpha 2-adrenoceptor antagonists.
    Durcan MJ; Wozniak KM; Linnoila M
    Br J Pharmacol; 1991 Jan; 102(1):222-6. PubMed ID: 1675146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats.
    Bouhelal R; Loubatières-Mariani MM; Mir AK
    Br J Pharmacol; 1990 May; 100(1):173-9. PubMed ID: 2142614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
    Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
    Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons.
    Ahlers ST; Weissman BA; Barrett JE
    J Pharmacol Exp Ther; 1992 Feb; 260(2):474-81. PubMed ID: 1531359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 5-HT1-like receptor mediates a sympathetic ganglionic hyperpolarization.
    Gilbert MJ; Newberry NR
    Eur J Pharmacol; 1987 Dec; 144(3):385-8. PubMed ID: 2964375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of putative 5-HT1A receptor antagonists on 8-OH-DPAT-induced hypothermia in rats and mice.
    Moser PC
    Eur J Pharmacol; 1991 Feb; 193(2):165-72. PubMed ID: 1828767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia.
    Bill DJ; Knight M; Forster EA; Fletcher A
    Br J Pharmacol; 1991 Aug; 103(4):1857-64. PubMed ID: 1833017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism of 8-OH-DPAT-induced behaviour in rats.
    Berendsen HH; Broekkamp CL; Van Delft AM
    Eur J Pharmacol; 1990 Oct; 187(1):97-103. PubMed ID: 2148726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats.
    Valenta B; Kotai E; Weisz E; Singer EA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S68-74. PubMed ID: 1702489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Hydroxytryptamine 1A (5HT1A) receptors mediate increases in plasma glucose independent of corticosterone.
    Gehlert DR; Shaw J
    Eur J Pharmacol; 2014 Dec; 745():91-7. PubMed ID: 25446927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
    Parsons AA; Motevalian M; Whalley ET
    Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.
    Bagdy G; Calogero AE; Murphy DL; Szemeredi K
    Endocrinology; 1989 Nov; 125(5):2664-9. PubMed ID: 2551661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.